Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Rituximab Treatment to Inhibit HLA Antibodies in Renal Allograft Recipients

NCT00261547 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00261547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00261547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Rituximab Treatment to Inhibit HLA Antibodies in Renal Allograft Recipients
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Withdrawn
Start date
December 31, 2005
Completion date
November 30, 2007
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rejection, kidney insufficiency